The secret of the Indian version of ruxolitinib/ruxolitinib cream: know the quality and price!

Ruxolitinib cream is a Janus kinase (JAK) inhibitor that is widely used to treat mild to moderate atopic dermatitis (AD) and non-segmental vitiligo. As an innovative topical drug, it reduces the inflammatory response by inhibiting the JAK-STAT signaling pathway and promotes the recovery of melanocytes in patients with vitiligo. At present, the original version of ruxolitinib cream has been launched in Europe and the United States. However, due to its high price, many patients have begun to pay attention to the more affordable Indian version or generic drugs from other countries.

Currently, no generic version of ruxolitinib cream is produced or officially sold in India. Although India is famous for high-quality, low-cost generic drugs, Indian pharmaceutical companies have not yet launched a generic version of ruxolitinib cream due to restrictions on patent protection and market demand. However, India may sell the drug through imports, such as offering the original version from the United States, Europe or a Bangladeshi generic version. In addition, some medical institutions in India may provide JAK inhibitors with similar mechanisms of action as alternative treatment options.

If the ruxolitinib cream that patients buy in India is an original drug produced in the United States or Europe, then its quality is consistent with that of the European and American markets, and its efficacy and safety have undergone strict supervision and clinical verification. Bangladesh is one of the first countries to launch a generic version of ruxolitinib cream. It is produced by a well-known generic pharmaceutical factory. The ingredients are the same as the original drug and the price is relatively cheaper. The production standards of Bangladeshi generic drugs are relatively high, and some companies have obtained certification from European and American drug regulatory agencies. Therefore, the quality is relatively competitive in the global generic drug market.

If unapproved informal drugs appear in the Indian market, patients need to be careful to identify them to ensure that the drugs purchased are of reliable quality. It is recommended to obtain medicines through regular hospitals, international pharmacies or cross-border medical channels to avoid purchasing counterfeit medicines or products of questionable quality.

Reference: https://www.opzelura.com/